Registry and Monitoring of ImmuNe-mediated Inflammatory Diseases

Not yet recruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

February 28, 2023

Study Completion Date

December 31, 2026

Conditions
ImmuNe-Mediated Inflammatory Diseases
Interventions
OTHER

Questionnaires

This is a collection of data from normal clinical routine: patients will be asked to record the assessments they undergo during their course of treatment, without changing clinical practice in any way. Data inherent to the following procedures will be collected: examinations, laboratory tests, imaging tests, questionnaires and rating scales.

Trial Locations (1)

20161

IRCCS Istituto Ortopedico Galeazzi, Milan

All Listed Sponsors
lead

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

OTHER

NCT05172284 - Registry and Monitoring of ImmuNe-mediated Inflammatory Diseases | Biotech Hunter | Biotech Hunter